Our Philosophy

     Whether it deals with life sciences, materials, or other areas of high impact, molecular discovery remains a long and tedious process. In practice, developing a new anticancer drug, a new catalyst for asymmetric transformations or a new methodology for "green" synthesis takes years. Our approach is to integrate advanced organic synthesis, computational chemistry, and biological testing to significantly improve the molecular discovery rate.





Areas of Interest

Organic Chemistry, Medicinal Chemistry, and Asymmetric Synthesis

  • Design, synthesis, and evaluation of potential drugs targeting SARS-CoV-2 - relevant publications here

  • Design, synthesis, and evaluation of potential drugs with a focus on Alzheimer's disease and cancer - relevant publications here

  • Development of novel methodologies for the synthesis of chiral cyclic and bicyclic scaffolds - relevant publications here

  • Directing Protecting Groups: a novel concept for green and regioselective transformations of amines and alcohols - relevant publications here

  • Design, synthesis and evaluation of asymmetric catalysts - relevant publications here

  • Computational Chemistry

  • Development of Fitted - a docking program used for predicting drug binding mode and potency - relevant publications here

  • Development of Impacts - predicting the sites of metabolism of drugs by Cytochrome P450 enzymes - relevant publications here

  • Development of Forecaster - drug discovery at a click of a button - relevant publications here

  • Development of Virtual Chemist - a virtual screening tool in the field of asymmetric catalyst design - relevant publications here

  • Development of H-TEQ - a novel method of obtaining parameters for molecular mechanics calculations - relevant publications here
  • Nucleoside modeling for streamlining the synthesis of nucleoside-based drugs - relevant publications here

  • Integrated Experimental and Computational Chemistry

  • Computer-aided design and synthesis of biologically relevant compounds

  • Computer-aided design and synthesis of novel asymmetric catalysts

  • Funding Agencies and Partners

    mcgill promote nserc frqnt ccg cihr mi4 mfi mfi